Generate Biomedicines, Inc.
PricedNASDAQ Global Select: GENB
Generate Biomedicines, Inc. IPO
Monitoring
S-1 Filed
Priced
Trading
Offering size
$400M
Range: 16.00
Exchange
NASDAQ Global Select
Ticker: GENB
Status
Priced
IPO date
Feb 27, 2026
IPO timeline
Upcoming
S-1 filed with SEC
Initial registration statement submitted to the Securities and Exchange Commission.
Feb 27, 2026
First-day trading
Shares available on the open market.
Frequently asked questions
When is Generate Biomedicines, Inc. going public?
Generate Biomedicines, Inc. has been priced and is expected to begin trading on Feb 27, 2026.
What is Generate Biomedicines, Inc.'s IPO valuation?
The estimated offering value is $400M, with a preliminary price range of 16.00. Final valuation will be determined at pricing.
What exchange will Generate Biomedicines, Inc. list on?
Generate Biomedicines, Inc. is expected to be listed on the NASDAQ Global Select. The ticker symbol is GENB.
Has Generate Biomedicines, Inc. filed an S-1 with the SEC?
No. As of the most recent data, Generate Biomedicines, Inc. has not filed a Form S-1 or other registration statement with the SEC.
Sources: FireStrike proprietary index · SEC EDGAR